Trilaciclib significantly reduced chemotherapy-induced myelosuppression in extensive-stage small cell lung cancer, which ...

The program of therapy prescribed for you depends on several factors including: tumor size, lymph node status, cell type, hormone receptor tests ... have 3 to 4 weeks off before beginning another ...

Chemotherapeutic agents are often used to treat cancer. They combat tumor growth, but also have a number of undesirable side ...

Significant contributions have been made by technological improvements in radiotherapy, as well as by the introduction of novel chemotherapy agents and dosing schedules. This article will review ...

A new research paper titled "Sacituzumab govitecan plus platinum-based chemotherapy ... Immunoblot analysis of cell lysates suggests perturbation of the cell-cycle and a shift towards pro ...

Chemotherapy ("chemo") is generally given in a series of intravenous (IV) infusions, known as a cycle, either on its ... called non-small cell lung cancer (NSCLC) and small cell lung cancer ...

Reduced-cycle chemotherapy plus lower-dose radiotherapy was highly effective in patients with stage I or II disease and favorable prognoses. The use of combined-modality therapy — doxorubicin ...

A doctor at a local cancer institute hopes to do more clinical studies to see if lab findings apply to actual patients. Read more at straitstimes.com.

Most patients with metastatic germ cell tumors (GCTs) are considered to have a good prognosis: cure rates >90% have been reported since the introduction of bleomycin, etoposide and cisplatin (BEP ...

The following is a summary of “Clinical significance and pro-oncogenic function of DBF4 in clear cell renal cell carcinoma,” published in the January 2025 issue of Urology by Chen et al. Clear cell ...

Approval follows results from the Phase III ECHO trial, which demonstrated that Calquence plus chemotherapy reduced the risk ...